Cryoport, Inc. (CYRX)
17.30
-0.06
(-0.32%)
USD |
NASDAQ |
Oct 08, 10:01
Cryoport Gross Profit Margin (Quarterly) : 39.66% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.66% |
| March 31, 2026 | 39.36% |
| December 31, 2025 | 40.73% |
| September 30, 2025 | 40.98% |
| June 30, 2025 | 40.21% |
| March 31, 2025 | 37.87% |
| December 31, 2024 | 39.55% |
| September 30, 2024 | 37.41% |
| June 30, 2024 | 36.67% |
| March 31, 2024 | 32.09% |
| December 31, 2023 | 32.61% |
| September 30, 2023 | 36.09% |
| June 30, 2023 | 36.54% |
| March 31, 2023 | 37.05% |
| December 31, 2022 | 37.13% |
| September 30, 2022 | 38.07% |
| June 30, 2022 | 39.18% |
| March 31, 2022 | 35.45% |
| December 31, 2021 | 34.57% |
| September 30, 2021 | 34.95% |
| June 30, 2021 | 45.21% |
| March 31, 2021 | 46.07% |
| December 31, 2020 | 28.18% |
| September 30, 2020 | 54.20% |
| June 30, 2020 | 54.61% |
| Date | Value |
|---|---|
| March 31, 2020 | 53.80% |
| December 31, 2019 | 53.37% |
| September 30, 2019 | 48.28% |
| June 30, 2019 | 51.26% |
| March 31, 2019 | 51.92% |
| December 31, 2018 | 49.49% |
| September 30, 2018 | 51.77% |
| June 30, 2018 | 54.11% |
| March 31, 2018 | 54.30% |
| December 31, 2017 | 51.57% |
| September 30, 2017 | 53.50% |
| June 30, 2017 | 47.75% |
| March 31, 2017 | 46.22% |
| December 31, 2016 | 42.21% |
| September 30, 2016 | 40.31% |
| June 30, 2016 | 40.78% |
| March 31, 2016 | 37.40% |
| March 31, 2015 | 30.88% |
| December 31, 2014 | 24.05% |
| September 30, 2014 | 27.27% |
| June 30, 2014 | 36.24% |
| March 31, 2014 | 17.15% |
| December 31, 2013 | 22.07% |
| September 30, 2013 | 12.44% |
| June 30, 2013 | 11.19% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 26.20% |
| Protect Pharmaceutical Corp. | -- |
| Champions Oncology, Inc. | 48.48% |
| Medpace Holdings, Inc. | 27.56% |
| Charles River Laboratories International, Inc. | 36.29% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.54% |
| Return on Assets | -4.29% |
| Return on Invested Capital | -4.48% |
| Profit Margin (Quarterly) | -16.86% |
| Operating Margin (Quarterly) | -20.56% |
| Return on Net Operating Assets | -9.49% |